La lutte contre la criminalité pharmaceutique (QO 005294C).

This parliamentary question focuses on the measures taken to fight crime within the pharmaceutical sector. It addresses the legal and regulatory challenges of preventing the production and distribution of illegal or counterfeit medicines to ensure public safety. This procedure primarily affects healthcare providers, pharmaceutical companies, and law enforcement agencies tasked with monitoring drug supply chains in Belgium.